Treatment and Prognostic Factors Affecting on Pancreatic Cancer Survival

DAI Yue-di,ZHANG De-xiang,YUAN Su-xu,TAO Li
DOI: https://doi.org/10.3969/j.issn.1007-3969.2011.03.011
2011-01-01
Abstract:Background and purpose:The prognosis of pancreatic cancer has had a history of poor.It still lacks an effective treatment modality and also has unknown prognostic factors.This study retrospectively analyzed the relationships between clinical characters,treatment and survival rates in order to detect the prognostic factors and best treatment models for pancreatic cancer.Methods:All pancreatic cancer patients with complete data of clinic characters and treatment were analyzed the prognostic factors,who had pathologic confirmed diagnosis and got survival through phone.Results:The median survival time of 302 pancreatic cancer patients was 6.1 months.The 1,2 and 3 year survival rates were 30.1%,10.6% and 2.6%,respectively.When analyzed by the Cox monopolar proportional hazards model,the tumor location,stage and treatment method were found to influence the survival of the pancreatic cancer patients(P≤0.01).The median survival time of patients with no therapy or best supportive therapy were 1.3 months.The median survival time for patients who underwent surgery,chemotherapy,biliary drainage,transcatheter arterial infusion chemotherapy and combined therapy were 11.0,7.3,3.5,9.0 and 11.0 months,respectively.All of the above mentioned treatments,mortality risk decreased significantly(P0.05).When analyzed by the Cox multivariate proportional hazards model,the tumor stage and treatment were independent prognostic factors(P0.01).Conclusion:Tumor stage and treatment were independent prognostic factors for pancreatic cancer.As for tumor locations in the head and neck,early staging,type of surgery,transcatheter arterial infusion chemotherapy,chemotherapy,biliary drainage and combined therapy could prolong the survival duration of pancreatic cancer patients.
What problem does this paper attempt to address?